Michael Raddatz, MD, PhD

My name is Michael Raddatz, and I am a cardiology fellow and physician-scientist at UCLA. My work has used in vitro, in vivo, and in silico approaches to define contributions of hematopoietic cells and inflammation to cardiovascular disease. Recent work with Alex Bick, MD, PhD at Vanderbilt has investigated the causes and consequences of clonal hematopoiesis of indeterminate potential (CHIP) and how this relates to cardiovascular morbidity. I am currently working with Jake Lusis, PhD to define and therapeutically target macrophage metabolism in atherosclerosis. I am broadly interested in finding ways to modulate the hematopoietic system to treat cardiovascular disease.

I was born in Austin, Texas and attended college at the University of Alabama, where I did research with David Dixon, PhD on peptide decomposition and John Kim, PhD on the effects of shear stress on cancer stem cell proteomics. I completed my PhD in Biomedical Engineering in the lab of Dave Merryman, PhD as part of the Vanderbilt MSTP supported by an NIH/NHLBI F30 predoctoral fellowship.

Outside of the medical center, I enjoy watching and playing basketball and soccer, hiking, and cooking with my wife and UCLA urogynecology fellow, Demetra, and cat, Moko.

I created this site to serve as a simple, clickable map to my work and ideas and associated organizations. Thank you for visiting!